Doctor profile · Federal record
Dr. Shanti Virupannavar, D.O.
Internal Medicine Physician (CMS: Rheumatology) · Okemos, MI
- NPI 1003109075
- Accepts Medicare
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2375 Woodlake Dr Ste 300
Okemos, MI 488646021
(517) 908-3600
fax (517) 908-3601
Credentials & registration
- NPI registered
- May 2011 — 15 yrs on file
- Profile last updated
- July 1, 2024
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- Michigan #5101019203
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1003109075. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
20,627
Distinct HCPCS
10
Medicare allowed
$496,286
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,800 | 30 | $13 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,050 | 17 | $40 | |
J0897 |
Injection, denosumab, 1 mg | 2,460 | 33 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 324 | 211 | $118 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 308 | 27 | $1 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 225 | 66 | $117 | |
J3489 |
Injection, zoledronic acid, 1 mg | 75 | 15 | $8 | |
96375 |
Injection of additional new drug or substance into vein | 71 | 18 | $14 | |
96372 |
Injection of drug or substance under skin or into muscle | 65 | 50 | $14 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 63 | 63 | $162 |
In context: peer comparison
Among 3 peers in Okemos Internal Medicine Physician, average services per provider: 715. This provider delivers 29× the peer median.Open Payments
Industry payments received
All-time total
$1,531
Transactions
104
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $250.95 | |
| Abbvie INC. | 21 | $214.14 | |
| Amgen INC. | 14 | $208.33 | |
| Ucb, INC. | 12 | $198.46 | |
| AstraZeneca Pharmaceuticals Lp | 10 | $172.46 | |
| Janssen Biotech, INC. | 19 | $162.84 | |
| Pfizer INC. | 5 | $89.93 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $38.59 | |
| Lilly USA, LLC | 2 | $36.06 | |
| Fresenius Kabi USA, LLC | 1 | $33.07 | |
| Alexion Pharmaceuticals, INC. | 1 | $23.65 | |
| Genzyme Corporation | 1 | $21.37 | |
| Fidia Pharma USA INC. | 1 | $19.91 | |
| Alvogen INC | 1 | $16.33 | |
| Aurinia Pharma U.S., INC. | 1 | $15.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,354
Patients
467
Total drug cost
$1,267,060
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 318 | 124 | $29,749 |
| Methotrexate (Methotrexate Sodium) | Brand | 242 | 87 | $11,097 |
| Prednisone | Generic | 215 | 110 | $3,078 |
| Sulfasalazine | Generic | 136 | 42 | $5,241 |
| Meloxicam | Generic | 96 | 49 | $1,206 |
| Alendronate Sodium | Generic | 65 | 26 | $1,058 |
| Celecoxib | Generic | 37 | 17 | $2,158 |
| Rinvoq (Upadacitinib) | Brand | 36 | 0 | $221,838 |
| Sulfasalazine Dr (Sulfasalazine) | Brand | 35 | 12 | $2,225 |
| Enbrel (Etanercept) | Brand | 33 | 0 | $234,224 |
Hospital affiliations
Frequently asked questions
What is Dr. Shanti Virupannavar's medical specialty?
Dr. Shanti Virupannavar practices Internal Medicine Physician in Okemos, MI.
Where does Dr. Shanti Virupannavar practice?
Dr. Shanti Virupannavar practices at 2375 Woodlake Dr Ste 300, Okemos, MI 488646021. Office phone: 5179083600.
What is Dr. Shanti Virupannavar's NPI?
Dr. Shanti Virupannavar's National Provider Identifier (NPI) is 1003109075, issued by NPPES.
Does Dr. Shanti Virupannavar accept Medicare assignment?
Yes. Dr. Shanti Virupannavar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shanti Virupannavar commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.